QPS, a global CRO providing discovery, preclinical and clinical drug development services, has announced the readiness of an access restricted bioanalysis lab prepared to analyze COVID-19 clinical trial samples. According to the World Health Organization (WHO), there are more than 20 vaccines for COVID-19 in development globally, and several therapeutics are in clinical trials. The WHO guidance classifies COVID-19 as Biohazard Safety Level-2 (BSL-2), which puts it in the same category as other ...